Although NfL non-specifically increases in several neurological diseases, it has the potential to differentiate AD from other dementias, particularly frontotemporal dementia (FTD) [16], which has also been validated in meta-analyses conducted by Bridel et al. [17] and Forgrave et al. [18]. This evidence concerns the gene NEFL and dementia.